Brief: PepGen Announces Issuance of US Patent for Proprietary PGN-EDODM1 Molecule
12/11/2025 12:14
Nov 12 (Reuters) - PepGen Inc PEPG.O: PEPGEN INC - ANNOUNCES USPTO ISSUANCE OF NEW PATENT FOR PGN-EDODM1 PEPGEN INC - PATENT PROVIDES EXCLUSIVITY FOR PGN-EDODM1 IN U.S. UNTIL 2042 Source text: ID:nBw4c24l3a Further company coverage: PEPG.O ((reuters.briefs@thomsonreuters.com;))
Recent news on PepGen
See all newsDyne, Sarepta shares tumble as Novartis setback weighs on muscle disease drug developers
PepGen Inc. reports results for the quarter ended June 30 - Earnings Summary
PepGen Q2 net loss narrows as expenses fall
Brief: PepGen Q2 EPS USD -0.26
PepGen Inc expected to post a loss of 29 cents a share - Earnings Preview